Parkinson’s gene therapy could improve motor symptoms

News

Author: Simge Eva DoganPublished: 14 November 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Young medical researcher

UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s.

The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences.

The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function.

To read more on this topic click here.

For more information on Parkinson’s and gene therapy please visit the EPDA website.


Read more:

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

Go Back

Share this story

Comments


Related articles


Ray Kennedy Cup

Interviews

The Ray Kennedy Cup: uniting Parkinson’s football teams from across Europe

An interview with Eigil Sabroe, the tournament’s organiser

READ MORE
SUMMER-SALAD-WHIT-CHICKEN

Recipes & Nutrition

Salad with chicken, apple & curry-yogurt dressing

This recipe offers a spicy yet cooling alternative to your standard salad

READ MORE
Neha Shadid Chaudry

Advances

This innovative walking stick may change the lives of Parkinson’s patients

Student receives £15,000 grant to develop smart walking stick

READ MORE